31 Oct 2019

 RA MEDICAL SYSTEMS DETAILS SUBSTANTIAL COMPLETION OF AUDIT COMMITTEE INVESTIGATION

  Ra Medical Systems Inc., a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announced Oct. 31 that the Audit Committee of the Board of Directors has substantially completed its internal investigation, announced in August. The Audit Committee, assisted by independent legal counsel,

0
26 Aug 2019

RA MEDICAL SYSTEMS RECEIVES NYSE NOTICE RELATED TO DELAY IN FORM 10-Q FILING

           Ra Medical Systems, Inc., a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, has announced that it received a notice from the NYSE indicating that Ra Medical is not in compliance with the NYSE’s continued listing requirements under the timely filing criteria

0
11 Dec 2018

RA MED SYSTEMS NEAR COMPLETION OF IPO OFFERING

  Ra Medical Systems has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering. No pricing details were given in the filing, but the offering is valued up to $86.25 million. The company intends to list its shares on the New

0